LC–MS/MS characterization of forced degradation products of zofenopril

Antioxidant and Cardioprotective Properties of the Sulphydryl Angiotensinconverting Enzyme Inhibitor Zofenopril

Stefano Evangelista, Stefano Manzini · Journal of International Medical Research · 2005 · 77 citations

Medicine, Cardiology, Pharmacology +17

Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties

Alessandro Subissi, Stefano Evangelista, Antonio Giachetti · Cardiovascular Drug Reviews · 1999 · 67 citations · Full text

Medicine, Cardiology, Pharmacology +16

LC–MS/MS studies of ritonavir and its forced degradation products

R. Nageswara Rao, Bondigalla Ramachandra, R. Mastan Vali et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 52 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +9

Effects of the Early Administration of Zofenopril on Onset and Progression of Congestive Heart Failure in Patients With Anterior Wall Acute Myocardial Infarction**This study was supported by a grant from Bristol-Myers Squibb Institute for Pharmaceutical Research, which was not involved in the acquisition or management of data and did not have access to unblinded information.

Claudio Borghi, Ettore Ambrosioni, Bruno Magnani · The American Journal of Cardiology · 1996 · 29 citations · Full text

Medicine, Cardiology, Pharmacology +12

Separation and characterization of forced degradation products of abacavir sulphate by LC–MS/MS

R. Nageswara Rao, R. Mastan Vali, Bondigalla Ramachandra et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 24 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +8